Krystal Biotech Inc
General ticker "KRYS" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $5.2B
Krystal Biotech Inc follows the US Stock Market performance with the rate: 53.6%.
Estimated limits based on current volatility of 2.7%: low 157.27$, high 166.04$
Factors to consider:
- Earnings for 9 months up through Q3 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2023-12-31 to 2025-12-30
- 2023-12-31 to 2024-12-30 estimated range: [83.96$, 153.63$]
- 2024-12-30 to 2025-12-30 estimated range: [70.21$, 132.75$]
Financial Metrics affecting the KRYS estimates:
- Negative: Non-GAAP EPS, $ of -3.38 <= 0.10
- Negative: Operating profit margin, % of -68.40 <= 1.03
- Negative: Operating cash flow per share per price, % of -2.88 <= 2.35
- Positive: -0.25 < Return on assets ratio (scaled to [-100,100]) of 1.32
- Negative: Industry operating cash flow per share per price (median), % of -23.87 <= 3.85
- Negative: Inventory ratio change, % of 12.11 > 1.08
- Positive: Industry inventory ratio change (median), % of 0 <= 0
Short-term KRYS quotes
Long-term KRYS plot with estimates
Financial data
| YTD | 2021-12-31 | 2022-12-31 | 2023-12-31 |
|---|---|---|---|
| Operating Revenue | $0.00MM | $0.00MM | $50.70MM |
| Operating Expenses | $68.28MM | $145.20MM | $160.43MM |
| Operating Income | $-68.28MM | $-145.20MM | $-109.73MM |
| Non-Operating Income | $-1.29MM | $5.22MM | $122.62MM |
| Interest Expense | $1.49MM | $0.00MM | $0.00MM |
| R&D Expense | $27.88MM | $42.46MM | $46.43MM |
| Income(Loss) | $-69.57MM | $-139.97MM | $12.90MM |
| Taxes | $0.00MM | $0.00MM | $1.97MM |
| Profit(Loss) | $-69.57MM | $-139.97MM | $10.93MM |
| Stockholders Equity | $593.58MM | $522.23MM | $778.64MM |
| Inventory | $0.00MM | $0.00MM | $6.99MM |
| Assets | $626.29MM | $558.45MM | $818.36MM |
| Operating Cash Flow | $-47.94MM | $-100.57MM | $-88.80MM |
| Capital expenditure | $68.34MM | $52.98MM | $11.80MM |
| Investing Cash Flow | $-226.77MM | $-114.08MM | $82.64MM |
| Financing Cash Flow | $347.69MM | $35.35MM | $202.75MM |
| Earnings Per Share* | $-3.13 | $-5.49 | $0.40 |
* EPS are Split Adjusted, recent splits may be reflected with a delay.